ICCC earnings: a negative outcome, -11.3%

On November 21, 2022, ImmuCell Corporation reached its earnings. The result was a negative outcome, and the stock moved -11.3% in the window around the event. It had already run -9.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.